Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor
GlobeNewswire
*Ad hoc announcement pursuant to Art. 53 LR*
*Allschwil, Switzerland – May 21, 2024*Idorsia Ltd (SIX: IDIA) today..
*Ad hoc announcement pursuant to Art. 53 LR*
*Allschwil, Switzerland – May 21, 2024*Idorsia Ltd (SIX: IDIA) today..
WAKIX^® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-YearSupplemental New Drug..
The latest data from the pivotal Transpher A and long-term follow-up studies will be presented at WORLDSymposium™..